Literature DB >> 16578076

A Table Determining L.D.50 or the Fifty Per Cent End-Point.

J Worcester1, E B Wilson.   

Abstract

Year:  1943        PMID： 16578076      PMCID： PMC1078591          DOI： 10.1073/pnas.29.7.207

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

1.  The intracerebral mouse-protection test for pertussis vaccines.

Authors:  J O IRWIN; A F STANDFAST
Journal:  J Hyg (Lond)       Date:  1957-03

2.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  USE OF MOVING AVERAGES AND INTERPOLATION TO ESTIMATE MEDIAN-EFFECTIVE DOSE: I. Fundamental Formulas, Estimation of Error, and Relation to Other Methods.

Authors:  W R Thompson
Journal:  Bacteriol Rev       Date:  1947-06

4.  Western equine encephalomyelitis vaccine produced in chick embryo cell cultures.

Authors:  D M Robinson; S Berman; J P Lowenthal; F M Hetrick
Journal:  Appl Microbiol       Date:  1966-11

5.  Preparation of cholera vaccines by fluorocarbon extraction of cholera Vibrio suspensions.

Authors:  P L Altieri; S Berman; A Groffinger; J P Lowenthal
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

6.  An analysis of the Wilson-Worcester method for determining the median effective dose of pertussis vaccine.

Authors:  M PITTMAN; J E LIEBERMAN
Journal:  Am J Public Health Nations Health       Date:  1948-01

7.  Pertussis and aureomycin.

Authors:  J A BELL; M PITTMAN; B J OLSON
Journal:  Public Health Rep       Date:  1949-05-13       Impact factor: 2.792

8.  Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.

Authors:  M E Rodriguez; D F Hozbor; O M Yantorno
Journal:  J Ind Microbiol       Date:  1996-07

9.  Mouse potency assay for Western equine encephalomyelitis vaccines.

Authors:  D M Robinson; S Berman; J P Lowenthal
Journal:  Appl Microbiol       Date:  1972-01

10.  Protective antigens from El Tor vibrios. 1. The preparation and properties of a purified protective antigen from an El Tor vibrio (Ogawa subtype).

Authors:  Y Watanabe; W F Verwey
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.